Inducible ischemia
Looks for new or worsening regional wall-motion abnormalities that may occur when part of the heart receives insufficient blood during stress.
A monitored heart ultrasound that uses intravenous dobutamine to make the heart work harder, helping assess blood flow, heart-muscle response and selected valve conditions when exercise testing is not suitable.
Dobutamine Stress Echocardiography, commonly called DSE, combines an echocardiogram with a carefully controlled medicine-based stress test. Dobutamine is given gradually through an intravenous line. It increases the strength and rate of the heartbeat, producing an effect similar to exercise while ultrasound images are recorded.
The cardiology team compares images taken at rest with images captured at increasing levels of stress. A healthy heart muscle normally contracts more strongly as workload rises. A region supplied by a significantly narrowed coronary artery may not increase its contraction normally and may develop a new wall-motion abnormality during stress.
Resting heart images, ECG, heart rate and blood pressure are recorded before medicine is started.
Dobutamine is increased in stages while the team continuously watches your response.
The cardiologist compares heart-muscle movement at rest and during stress.
The test protocol and interpretation depend on the exact clinical question, resting heart function and the patient’s ability to exercise.
Looks for new or worsening regional wall-motion abnormalities that may occur when part of the heart receives insufficient blood during stress.
May help assess the functional importance of suspected or known coronary artery disease and support further treatment planning.
Low-dose dobutamine may identify heart muscle with contractile reserve that could potentially improve after restoration of blood flow.
A specialised low-dose protocol may help distinguish true severe from pseudo-severe aortic stenosis in selected patients with reduced left-ventricular function.
May be considered before selected non-cardiac operations when the result is expected to influence management and exercise testing is unsuitable.
Assesses heart rate, blood-pressure response, global pumping function and symptoms together with real-time ultrasound findings.
Dobutamine stress testing is generally selected when stress imaging is needed but adequate exercise is not possible or an exercise-based study is unlikely to answer the clinical question.
The medication dose, target response and measurements are selected according to the purpose of the test. These protocols are not interchangeable.
The dose is increased in stages to raise the heart rate and workload. Images are reviewed for new wall-motion abnormalities that may indicate inducible ischemia.
Small doses are used to see whether weakened heart-muscle segments improve their contraction, suggesting preserved contractile reserve.
A carefully controlled low-dose study measures valve gradients, valve area, stroke volume and contractile reserve in selected patients.
Preparation instructions can vary according to the hospital protocol, your medicines and the reason for testing. Follow the instructions given specifically for your appointment.
The test is performed in a monitored setting with staff and medicines available to treat symptoms or rhythm changes if they occur.
The team checks symptoms, medical history, medicines, allergies, previous test results and whether any condition makes stress testing unsuitable that day.
ECG electrodes and a blood-pressure cuff are applied. Resting heart rate, rhythm, blood pressure and echocardiographic images are recorded.
A small IV cannula is inserted, usually in the arm. Dobutamine is delivered through an infusion pump in carefully controlled stages.
The dose is increased according to the protocol. Atropine may be added in selected patients if the heart rate response remains insufficient.
Ultrasound images are captured at different stress stages while symptoms, ECG, blood pressure, heart rate and wall motion are continuously assessed.
The infusion is stopped after the required endpoint or earlier for symptoms, diagnostic findings or safety reasons. Monitoring continues until you are stable.
Dobutamine is intended to make the heart work harder. Temporary sensations are therefore common and usually settle after the infusion is stopped.
You may notice a faster or stronger heartbeat, palpitations or a pounding sensation as the medication dose increases.
Warmth, flushing, headache, tremor, nausea, anxiety or mild shortness of breath can occur during the infusion.
Tell the team immediately about chest pain, marked breathlessness, dizziness, weakness or any unusual symptom. Do not wait for the test to finish.
DSE is widely used and is generally safe when appropriately prescribed and performed with continuous monitoring. It intentionally stresses the heart, so careful screening and supervision are essential.
The cardiologist interprets wall motion together with symptoms, ECG changes, blood-pressure response, heart rate and the purpose-specific measurements.
The next step depends on whether the result is normal, abnormal, inconclusive or performed for valve or viability assessment.
Dr. Kiran Lakkireddy provides evidence-based cardiac evaluation with a focus on accurate diagnosis, transparent communication and individualised treatment planning. His clinical practice includes complex coronary intervention, congenital cardiac intervention and advanced structural-heart therapies.
Clear answers to common questions about Dobutamine Stress Echocardiography.
Book a cardiac consultation to review the indication, medication instructions, previous reports and the safest next step in your evaluation.